Everything you need to know about thyroid cancer, from early warning signs to treatment options. Doctors reveal crucial ...

In honor of Thyroid Awareness Month, we are exploring the causes of thyroid diseases and thyroid cancer in our community.

A 5-year follow-up of those randomized to receive or not receive radioiodine after thyroidectomy showed nearly the same low ...

"well-differentiated" means the cancer cells resemble the normal cells from which they grew. Well-differentiated cancers grow more slowly and have a better prognosis than undifferentiated cancers, ...

program were used to calculate annual age-adjusted incidence and mortality rates for thyroid cancer (categorized as papillary, follicular, medullary, or anaplastic). Between 1973 and 2002 ...

Poorly differentiated and well-differentiated thyroid cancers can be present at the same time. Hurthle cell thyroid cancer (also called Hurtle cell carcinoma) is a rare sub-type of follicular thyroid ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer.

It has long been known that the incidence of thyroid cancer in women is significantly higher than that in men. The objective of this article is to review gender differences in thyroid cancer ...

January is Thyroid Awareness Month. Learn how to spot the signs of thyroid issues and take proactive steps toward better ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.